Mediolanum International Funds Ltd Buys 158,726 Shares of CVS Health Corporation $CVS

Mediolanum International Funds Ltd grew its position in CVS Health Corporation (NYSE:CVS) by 610.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 184,715 shares of the pharmacy operator’s stock after purchasing an additional 158,726 shares during the quarter. Mediolanum International Funds Ltd’s holdings in CVS Health were worth $12,651,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Avion Wealth grew its position in shares of CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares during the last quarter. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health in the second quarter valued at approximately $30,000. Bell Investment Advisors Inc grew its stake in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares during the last quarter. Roxbury Financial LLC increased its position in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares during the period. Finally, ORG Partners LLC boosted its holdings in CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently issued reports on CVS shares. Truist Financial restated a “buy” rating and set a $95.00 price target (up from $92.00) on shares of CVS Health in a research note on Thursday, October 30th. Argus upped their target price on CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Robert W. Baird upgraded shares of CVS Health from a “neutral” rating to an “outperform” rating and lifted their price target for the stock from $71.00 to $82.00 in a research note on Thursday, August 14th. Raymond James Financial raised their price objective on shares of CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Finally, Sanford C. Bernstein upped their target price on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research note on Friday, September 5th. Two analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $89.41.

CVS Health Price Performance

CVS opened at $77.92 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.62. The stock has a market capitalization of $98.91 billion, a P/E ratio of 205.06, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60. The company’s 50 day simple moving average is $78.12 and its 200-day simple moving average is $70.25. CVS Health Corporation has a one year low of $43.56 and a one year high of $85.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period last year, the company earned $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. CVS Health’s dividend payout ratio is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.